Tower Research Capital LLC (Trc) Kamada LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Kamada LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 239 shares of KMDA stock, worth $1,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239
Previous 45
431.11%
Holding current value
$1,388
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding KMDA
# of Institutions
33Shares Held
6.48MCall Options Held
200Put Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.83MShares$10.6 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$8.04 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny856KShares$4.97 Million0.01% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3710KShares$4.12 Million0.4% of portfolio
-
Wells Fargo & Company San Francisco, CA630KShares$3.66 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $260M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...